A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)

PHASE4RecruitingINTERVENTIONAL

Enrollment

225

Participants

Timeline

Start Date

September 18, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

August 31, 2025

Conditions

ObesityOverweight

Interventions

BEHAVIORAL

WW Clinic

Telehealth platform that specializes in medical weight management and integrates the behavioral and lifestyle support from WW.

DRUG

Bupropion-Naltrexone

DRUG

Bupropion-Naltrexone-Metformin

Trial Locations (1)

RECRUITING

WW International, Inc, New York

All Listed Sponsors

lead

Michelle Cardel, PhD, MS, RD

INDUSTRY